Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of TAK-816 vs ActHIB in Healthy Infants
NCT01379846Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2011
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of haemophilus influenzae type b vaccine in Haemophilus influenzae type b infection (Hib), sponsored by Takeda. Started Jun 2011; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01379846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379846.